We performed transluminal re-canalization by needle puncture under fluoro-endoscopic control on a total of ten patients (membranous urethra, 8; bulbous urethra, 2) with complete obliteration after traumatic urethral disruption. The re-canalized tract was created by balloon dilation, internal urethrotomy or endoscopic resection of the scar tissue. The patient age ranged from 10 to 57 years (mean age; 37.9 +/- 15.3 years). A transluminal puncture was attempted in three patients by transperineal-transurethral approach and in seven by transurethral approach. In one of them, who sustained a complete membranous disruption 5 weeks ago, transluminal puncture failed because of the movable proximal urethra. The remaining nine patients voided without difficulty for the mean follow-up period of 18.1 +/- 14.3 months (range: 2-46). Three patients had mild stress urinary incontinence. A transluminal puncture is less invasive, safe and reliable for re-establishment of the true proximal part of the disrupted urethra. It can be recommended as a useful technique for endo-urological re-establishment for a completely obliterated urethra. Although this endoscopic re-establishment requires urethral sounding or internal urethrotomy for 6 months postoperatively, it may be an alternative to conventional surgical repair.

Morbidity rates were acceptable and functional outcome was excellent in this rather large group of patients who underwent Hautmann neobladder construction. Some problems have not been fully overcome, however, i.e., nocturnal incontinence and sexual dysfunction.

Quantification of argyrophilic nucleolar organizer regions (AgNORs) stained by the silver colloid method in urinary exfoliative cells from 36 benign urological diseases and 33 transitional cell carcinomas (TCC) of the urinary bladder was carried out. Also, AgNORs of these cells were measured by means of the computer-assisted image analysis system. There was a significant correlation between AgNORs numbers of cells from voided or wash-out smears and those from touch smears (p less than 0.01). The mean AgNOR numbers per nucleus showed a stepwise increase from non-infected benign urological diseases (mean +/- SD: 3.33 +/- 0.60) through infected urological diseases (3.88 +/- 0.58), grade 1 of TCC (5.23 +/- 1.39) and grade 2 of TCC (6.34 +/- 0.86), to grade 3 of TCC (8.09 +/- 1.19). The maximum number of AgNORs in each group indicated almost the same results. The estimation of the distribution of the maximum AgNOR number might be of great value for rapid and reliable detection of bladder cancers. Moreover, the computer-assisted image analysis of AgNORs could offer an objective index for the cytological assessment of urinary bladder diseases including TCC.

Transurethral endoureteropyelotomy was performed in a total of 37 patients with primary ureteropelvic junction obstruction or various ureteral strictures. Thirty-one (84%) of the 37 evaluable patients showed a radiographical improvement of hydronephrosis with a mean follow-up period of 15.8 +/- 10.5 months (range: 3-40). The clinical success rates were as follows: primary ureteropelvic junction obstruction, 11/12 92%); upper ureteral stricture, 6/7 (86%); lower ureteral stricture, 14/18 (78%). This endourological procedure required a mean operation time of 38.0 +/- 27.7 minutes and hospital stay of 7.3 +/- 4.9 days. No major complication has been identified. This retrograde procedure has a straight access to the strictured segment of ureteropelvic junction. It is safe and less invasive to the renal parenchym as it does not require percutaneous nephrostomy. Therefore, it might be clinically useful for the treatment of primary ureteropelvic junction obstruction and other ureteral strictures.

Background Immune-mediated pneumonitis has a high mortality rate; however, little is known about the related risk factors. We analyzed the risk factors for pneumonitis, such as smoking and lung metastasis (LM), among extrapulmonary primary tumors. Methods We retrospectively collected data of 110 patients treated with immune checkpoint inhibitors (ICIs) (nivolumab/pembrolizumab) for extrapulmonary primary tumors at the Shiga University of Medical Science Hospital, between January 2015 and December 2019. The frequency of pneumonitis was evaluated based on the time between the start of ICI treatment and the onset of symptomatic or all pneumonitis. The severity of pneumonitis was graded according to the Common Terminology Criteria for Adverse Events, version 5.0. We analyzed the risk factors, such as the absence or presence of interstitial lung disease (ILD) and lung metastases (LMs), or other clinical factors, including smoking status before ICI administration. Results The Cox proportional hazards regression analysis revealed that the smoking index and presence of ILD were significant factors for an increased rate of all pneumonitis (hazard ratio [HR] = 20.3, 95% confidence interval [CI] = 20.0–20.4; p = 0.02 and HR = 4.3, 95% CI = 1.2–12.1; p = 0.03, respectively). LM was significantly related to an increased rate of symptomatic pneumonitis (HR = 6.8, 95% CI = 1.3–124.2; p = 0.02). Conclusions Smoking index and ILD were the significant risk factors for ICI-induced pneumonitis. LM was a significant risk factor for ICI-induced symptomatic pneumonitis. Therefore, pre-screening for ILD and LM and the recognition of patients’ smoking histories are important for determining the risk of ICI-induced pneumonitis and allowing safe ICI administration.